clobetasone butyrate has been researched along with Otitis Externa in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nemeth, Z; Verdolini, R; Verga, E | 1 |
1 other study(ies) available for clobetasone butyrate and Otitis Externa
| Article | Year |
|---|---|
Topical treatment of eczematous external otitis involving the ear canal: long-term results of a trial comparing pimecrolimus 1 per cent versus clobetasone butyrate 0.05 per cent.
Topics: Administration, Topical; Clobetasol; Ear Canal; Humans; Otitis Externa; Tacrolimus | 2022 |